CH617196A5 - - Google Patents

Download PDF

Info

Publication number
CH617196A5
CH617196A5 CH731075A CH731075A CH617196A5 CH 617196 A5 CH617196 A5 CH 617196A5 CH 731075 A CH731075 A CH 731075A CH 731075 A CH731075 A CH 731075A CH 617196 A5 CH617196 A5 CH 617196A5
Authority
CH
Switzerland
Prior art keywords
methyl
compounds
compound
formula
preparation
Prior art date
Application number
CH731075A
Other languages
German (de)
English (en)
Inventor
Edmund Carl Kornfeld
Nicholas James Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH617196A5 publication Critical patent/CH617196A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH731075A 1974-06-06 1975-06-06 CH617196A5 (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US477136A US3901894A (en) 1974-06-06 1974-06-06 8-thiomethylergolines

Publications (1)

Publication Number Publication Date
CH617196A5 true CH617196A5 (is) 1980-05-14

Family

ID=23894677

Family Applications (1)

Application Number Title Priority Date Filing Date
CH731075A CH617196A5 (is) 1974-06-06 1975-06-06

Country Status (27)

Country Link
US (1) US3901894A (is)
JP (1) JPS582946B2 (is)
AR (1) AR210736A1 (is)
AT (1) AT344333B (is)
AU (1) AU507574B2 (is)
BE (1) BE829887A (is)
BG (1) BG24812A3 (is)
CA (1) CA1071623A (is)
CH (1) CH617196A5 (is)
CS (1) CS199591B2 (is)
DD (1) DD120438A5 (is)
DE (1) DE2524575A1 (is)
DK (1) DK144160C (is)
ES (1) ES438313A1 (is)
FR (1) FR2273542A1 (is)
GB (1) GB1505296A (is)
HU (1) HU173590B (is)
IE (1) IE41474B1 (is)
IL (1) IL47424A (is)
NL (1) NL180911C (is)
PH (1) PH10992A (is)
PL (1) PL95738B1 (is)
RO (1) RO77543A (is)
SE (1) SE420095B (is)
SU (1) SU613724A3 (is)
YU (1) YU145575A (is)
ZA (1) ZA753638B (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147789A (en) * 1974-03-14 1979-04-03 Sandoz Ltd. 6-Methyl-8-thiomethyl-ergolene derivatives
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
JPS5283894A (en) * 1976-01-01 1977-07-13 Lilly Co Eli 88thiomethyl ergoline
GB1549829A (en) * 1976-05-26 1979-08-08 Farmaceutici Italia 10'-methoxy-1',6'-dimethylergoline-8'-beta-methyl-amino(or thio)-pyrazines
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4180582A (en) * 1978-02-08 1979-12-25 Eli Lilly And Company 6-n-Propyl-8-methoxy-methyl or methylmercaptomethylergolines and related compounds as prolactin inhibitors and to treat Parkinson's syndrome
US4202979A (en) * 1979-01-11 1980-05-13 Eli Lilly And Company 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
FR2526797A1 (fr) * 1982-05-12 1983-11-18 Roussel Uclaf Nouveaux derives de l'acide 9-oxalysergique, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
GB8427536D0 (en) * 1984-10-31 1984-12-05 Lilly Industries Ltd Ergoline derivatives
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
US4801712A (en) * 1985-06-24 1989-01-31 Eli Lilly And Company 2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
WO2002100888A1 (en) * 2001-06-08 2002-12-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin-dopamine chimeric analogs
EP1485382B1 (en) * 2002-03-15 2008-11-19 Antibioticos S.p.A. Process for the synthesis of pergolide
CN104768565B (zh) 2012-11-01 2017-04-26 益普生制药股份有限公司 促生长素抑制素类似物及其二聚体
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507248A (de) * 1967-03-16 1971-05-15 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung von D-6-Methylergolin(I)ylessigsäure
DE1935556A1 (de) * 1969-07-12 1971-01-21 Hoechst Ag Verfahren zur Herstellung von Lysergol
JPS5012398A (is) * 1973-06-08 1975-02-07

Also Published As

Publication number Publication date
CS199591B2 (en) 1980-07-31
GB1505296A (en) 1978-03-30
ATA427975A (de) 1977-11-15
CA1071623A (en) 1980-02-12
YU145575A (en) 1982-02-28
DD120438A5 (is) 1976-06-12
BG24812A3 (en) 1978-05-12
IL47424A (en) 1979-11-30
IE41474B1 (en) 1980-01-16
RO77543A (ro) 1982-02-26
IL47424A0 (en) 1975-08-31
DK144160B (da) 1981-12-28
NL180911C (nl) 1987-05-18
DK249975A (da) 1975-12-07
HU173590B (hu) 1979-06-28
AU507574B2 (en) 1980-02-21
ES438313A1 (es) 1977-05-16
AR210736A1 (es) 1977-09-15
FR2273542B1 (is) 1978-10-06
NL180911B (nl) 1986-12-16
IE41474L (en) 1975-12-06
NL7506584A (nl) 1975-12-09
JPS582946B2 (ja) 1983-01-19
PL95738B1 (pl) 1977-11-30
AU8182775A (en) 1976-12-09
SE7506327L (sv) 1975-12-08
PH10992A (en) 1977-10-20
DK144160C (da) 1982-06-07
JPS50160300A (is) 1975-12-25
SU613724A3 (ru) 1978-06-30
DE2524575A1 (de) 1975-12-18
US3901894A (en) 1975-08-26
ZA753638B (en) 1977-01-26
FR2273542A1 (fr) 1976-01-02
BE829887A (fr) 1975-12-05
AT344333B (de) 1978-07-10
SE420095B (sv) 1981-09-14

Similar Documents

Publication Publication Date Title
CH617196A5 (is)
EP0049355B1 (de) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridin oder chinolin)-3-carbonsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DD141928A5 (de) Verfahren zur herstellung neuer ergolinderivate
AT391867B (de) Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate
DE2415980C2 (is)
EP0160842B1 (de) 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD153372A5 (de) Verfahren zur herstellung von neuen ergolinderivaten
EP0133530B1 (de) 1,6-Naphthyridinon-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
CH649295A5 (de) Optisch aktive oder razemische brom-e-homo-eburanderivate.
DE2335750C3 (de) D-6-Methylergolin-derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH624962A5 (en) Process for the preparation of novel amide derivatives of dimeric vinblastin alkaloids
CH617197A5 (is)
DE2813286A1 (de) In 3'-stellung oxygenierte derivate von 4'-desoxy-vincaleukoblastin a und b sowie verwandte 1-formylverbindungen
DD150467A5 (de) Verfahren zur herstellung von dimeren vincaalkaloiden
AT332568B (de) Verfahren zur herstellung eines neuen d-2,6-dimethyl-8-cyano-(carboxamido)-methylergolins und von dessen salzen
EP0180833A1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
CH618983A5 (is)
DE1795150B2 (de) 2-alkyl-2,3-dihydrothieno eckige klammer auf 3,2-c eckige klammer zu chinoline, deren pharmazeutisch unbedenkliche nichttoxische salze mit saeuren und verfahren zu ihrer herstellung
DD290887A5 (de) Neue rifamycinderivate
CH647779A5 (de) Halogenierte 14-oxo-15-hydroxy-e-homoeburnaminderivate und verfahren zu ihrer herstellung.
AT345996B (de) Verfahren zur herstellung neuer amidderivate von vinblastin, leurosidin und leurocristin und ihrer saeureadditionssalze
CH644602A5 (de) Benzothiazocin- und benzothiazoninderivate, ihre herstellung und diese derivate enthaltende pharmazeutische praeparate.
DD208618A5 (de) Verfahren zur herstellung von ergotderivaten
AT385987B (de) Verfahren zur herstellung neuer ergolinderivate und ihrer salze
AT265541B (de) Verfahren zur Herstellung neuer 1,2α-Methylen-19-nor-testosterone

Legal Events

Date Code Title Description
PL Patent ceased